Paul Edward Kelly - 31 Dec 2022 Form 5 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul E. Kelly
Issuer symbol
RLMD
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
02 Feb 2023, 16:00:59 UTC
Previous filing
20 Dec 2022
Next filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Gift $0 -6,400 -99% $0.000000 41 08 Jul 2021 Common Stock 4,800 $13.80 Direct F1, F2
transaction RLMD Stock Option (right to buy) Gift $0 -19,600 -13% $0.000000 130,400 08 Jul 2021 Common Stock 19,600 $8.80 Direct F1, F3
transaction RLMD Stock Option (right to buy) Gift $0 -56,000 -37% $0.000000 94,000 08 Jul 2021 Common Stock 56,000 $43.47 Direct F1, F4
transaction RLMD Stock Option (right to buy) Gift $0 -18,000 -12% $0.000000 132,000 08 Jul 2021 Common Stock 18,000 $33.43 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust.
F2 The options were granted on November 12, 2015. 25% of the options vested one year from the grant date and the remaining 75% of the options vested in equal quarterly increments of 6.25% of the initial option grant over the following three year period.
F3 The options were granted on July 29, 2019. 6.25% of the options vest each quarter from the date of grant.
F4 The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant.
F5 The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant.